SIM
PDSB icon

Spark Investment Management’s PDS Biotechnology PDSB Stock Holding History

Spark Investment Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-863
Closed -$157K – 841
2017
Q1 		$157K Buy
+863
New +$171K 0.01% 739

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spark Investment Management's PDSB Position: Q2 2017 in Review

Spark Investment Management sold out of PDS Biotechnology (PDSB) in Q2 2017, closing a stake of 863 shares — an estimated $157K sold.

Spark Investment Management first reported a position in PDSB in Q1 2017 and held it in 1 quarter. The position peaked at $157K in Q1 2017. 54 funds tracked by Wall St. Rank hold PDSB as of Q2 2017.

  • Spark Investment Management reported no remaining PDS Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Spark Investment Management sold 863 PDS Biotechnology shares in Q2 2017, an estimated $157K.
  • Spark Investment Management first reported a position in PDS Biotechnology in Q1 2017 and held it in 1 quarter.
  • Spark Investment Management's PDS Biotechnology position peaked at $157K in Q1 2017.
  • 54 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2017.

Based on Spark Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.